Bredemolic Acid Ameliorates Selected Liver Function Biomarkers in a Diet-Induced Prediabetic Rat Model

Background. Prediabetes is an intermediary hyperglycaemic state that precedes type 2 diabetes mellitus (T2DM) in which abnormal metabolism of glucose and lipids occurs in organs such as the liver. Evidence has shown that, about 70% of T2DM patients develop hepatic dysfunction which is found to begin...

Full description

Bibliographic Details
Main Authors: Akinjide Moses Akinnuga, Angezwa Siboto, Bongiwe Khumalo, Ntethelelo Hopewell Sibiya, Phikelelani Ngubane, Andile Khathi
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2020/2475301
id doaj-c70503dbeafa423e9290aa04ac564f29
record_format Article
spelling doaj-c70503dbeafa423e9290aa04ac564f292020-11-25T02:08:41ZengHindawi LimitedCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972020-01-01202010.1155/2020/24753012475301Bredemolic Acid Ameliorates Selected Liver Function Biomarkers in a Diet-Induced Prediabetic Rat ModelAkinjide Moses Akinnuga0Angezwa Siboto1Bongiwe Khumalo2Ntethelelo Hopewell Sibiya3Phikelelani Ngubane4Andile Khathi5Department of Physiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Nata, Westville, Durban, South AfricaDepartment of Physiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Nata, Westville, Durban, South AfricaDepartment of Physiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Nata, Westville, Durban, South AfricaDepartment of Pharmacy and Pharmacology, Rhodes University, Grahamstown, South AfricaDepartment of Physiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Nata, Westville, Durban, South AfricaDepartment of Physiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Nata, Westville, Durban, South AfricaBackground. Prediabetes is an intermediary hyperglycaemic state that precedes type 2 diabetes mellitus (T2DM) in which abnormal metabolism of glucose and lipids occurs in organs such as the liver. Evidence has shown that, about 70% of T2DM patients develop hepatic dysfunction which is found to begin during the prediabetic stage. Bredemolic acid, a pentacyclic triterpene, has been found to improve insulin sensitivity in diet-induced prediabetic rats. The effects of this compound on liver function, however, are unknown. This study was therefore designed to investigate the effects of BA on liver function in high fat-high carbohydrate (HFHC) diet-induced prediabetic rats. Methods. Thirty-six (36) male rats that weigh 150 g–180 g were divided into two groups, the non-prediabetic (n = 6) and the prediabetic groups (n = 30) that were fed normal diet (ND) and HFHC diet, respectively. The prediabetic rats were further subdivided into five groups (n = 6) and treated with either BA (80 mg/kg) or metformin (MET, 500 mg/kg) every third day for 12 weeks. After 12 weeks, blood samples and the liver were collected for biochemical analysis. Results. The induction of prediabetes resulted in increased release of liver enzymes (AST and ALT), increased liver glycogen and triglyceride, lipid peroxidation, and decreased sterol regulatory element-binding protein (SREBP1c) and antioxidant enzymes. However, the administration of BA decreased liver enzyme concentrations, decreased hepatic oxidative stress, and improved antioxidant enzymes such as SOD and GPx. Conclusion. BA administration improved liver function in diet-induced prediabetic rats in the presence or absence of dietary intervention.http://dx.doi.org/10.1155/2020/2475301
collection DOAJ
language English
format Article
sources DOAJ
author Akinjide Moses Akinnuga
Angezwa Siboto
Bongiwe Khumalo
Ntethelelo Hopewell Sibiya
Phikelelani Ngubane
Andile Khathi
spellingShingle Akinjide Moses Akinnuga
Angezwa Siboto
Bongiwe Khumalo
Ntethelelo Hopewell Sibiya
Phikelelani Ngubane
Andile Khathi
Bredemolic Acid Ameliorates Selected Liver Function Biomarkers in a Diet-Induced Prediabetic Rat Model
Canadian Journal of Gastroenterology and Hepatology
author_facet Akinjide Moses Akinnuga
Angezwa Siboto
Bongiwe Khumalo
Ntethelelo Hopewell Sibiya
Phikelelani Ngubane
Andile Khathi
author_sort Akinjide Moses Akinnuga
title Bredemolic Acid Ameliorates Selected Liver Function Biomarkers in a Diet-Induced Prediabetic Rat Model
title_short Bredemolic Acid Ameliorates Selected Liver Function Biomarkers in a Diet-Induced Prediabetic Rat Model
title_full Bredemolic Acid Ameliorates Selected Liver Function Biomarkers in a Diet-Induced Prediabetic Rat Model
title_fullStr Bredemolic Acid Ameliorates Selected Liver Function Biomarkers in a Diet-Induced Prediabetic Rat Model
title_full_unstemmed Bredemolic Acid Ameliorates Selected Liver Function Biomarkers in a Diet-Induced Prediabetic Rat Model
title_sort bredemolic acid ameliorates selected liver function biomarkers in a diet-induced prediabetic rat model
publisher Hindawi Limited
series Canadian Journal of Gastroenterology and Hepatology
issn 2291-2789
2291-2797
publishDate 2020-01-01
description Background. Prediabetes is an intermediary hyperglycaemic state that precedes type 2 diabetes mellitus (T2DM) in which abnormal metabolism of glucose and lipids occurs in organs such as the liver. Evidence has shown that, about 70% of T2DM patients develop hepatic dysfunction which is found to begin during the prediabetic stage. Bredemolic acid, a pentacyclic triterpene, has been found to improve insulin sensitivity in diet-induced prediabetic rats. The effects of this compound on liver function, however, are unknown. This study was therefore designed to investigate the effects of BA on liver function in high fat-high carbohydrate (HFHC) diet-induced prediabetic rats. Methods. Thirty-six (36) male rats that weigh 150 g–180 g were divided into two groups, the non-prediabetic (n = 6) and the prediabetic groups (n = 30) that were fed normal diet (ND) and HFHC diet, respectively. The prediabetic rats were further subdivided into five groups (n = 6) and treated with either BA (80 mg/kg) or metformin (MET, 500 mg/kg) every third day for 12 weeks. After 12 weeks, blood samples and the liver were collected for biochemical analysis. Results. The induction of prediabetes resulted in increased release of liver enzymes (AST and ALT), increased liver glycogen and triglyceride, lipid peroxidation, and decreased sterol regulatory element-binding protein (SREBP1c) and antioxidant enzymes. However, the administration of BA decreased liver enzyme concentrations, decreased hepatic oxidative stress, and improved antioxidant enzymes such as SOD and GPx. Conclusion. BA administration improved liver function in diet-induced prediabetic rats in the presence or absence of dietary intervention.
url http://dx.doi.org/10.1155/2020/2475301
work_keys_str_mv AT akinjidemosesakinnuga bredemolicacidamelioratesselectedliverfunctionbiomarkersinadietinducedprediabeticratmodel
AT angezwasiboto bredemolicacidamelioratesselectedliverfunctionbiomarkersinadietinducedprediabeticratmodel
AT bongiwekhumalo bredemolicacidamelioratesselectedliverfunctionbiomarkersinadietinducedprediabeticratmodel
AT ntethelelohopewellsibiya bredemolicacidamelioratesselectedliverfunctionbiomarkersinadietinducedprediabeticratmodel
AT phikelelaningubane bredemolicacidamelioratesselectedliverfunctionbiomarkersinadietinducedprediabeticratmodel
AT andilekhathi bredemolicacidamelioratesselectedliverfunctionbiomarkersinadietinducedprediabeticratmodel
_version_ 1715562045169991680